<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><?release-delay 0|0 ?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id><journal-id journal-id-type="hwp">jbc</journal-id><journal-id journal-id-type="pmc">jbc</journal-id><journal-id journal-id-type="publisher-id">JBC</journal-id><journal-title-group><journal-title>The Journal of Biological Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0021-9258</issn><issn pub-type="epub">1083-351X</issn><publisher><publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name><publisher-loc>9650 Rockville Pike, Bethesda, MD 20814, U.S.A.</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19759016</article-id><article-id pub-id-type="publisher-id">M109.021832</article-id><article-id pub-id-type="doi">10.1074/jbc.M109.021832</article-id><article-categories><subj-group subj-group-type="heading"><subject>Protein Structure and Folding</subject></subj-group></article-categories><title-group><article-title>Naturally Occurring Mutations Alter the Stability of Polycystin-1 Polycystic Kidney Disease (PKD) Domains<xref ref-type="fn" rid="FN1">*</xref><xref ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"/></sup></xref></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Liang</given-names></name><xref ref-type="aff" rid="aff1"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Meixiang</given-names></name><xref ref-type="aff" rid="aff1"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Forman</surname><given-names>Julia R.</given-names></name><xref ref-type="aff" rid="aff2"><sup>&#x000a7;</sup></xref><xref ref-type="author-notes" rid="FN3"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Clarke</surname><given-names>Jane</given-names></name><xref ref-type="aff" rid="aff2"><sup>&#x000a7;</sup></xref><xref ref-type="author-notes" rid="FN4"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Oberhauser</surname><given-names>Andres F.</given-names></name><xref ref-type="aff" rid="aff1"><sup>&#x02021;</sup></xref><xref ref-type="aff" rid="aff3"><sup>&#x000b6;</sup></xref><xref ref-type="corresp" rid="cor1"><sup>3</sup></xref></contrib><aff id="aff1">From the <label>&#x02021;</label>Department of Neuroscience and Cell Biology and </aff><aff id="aff2"><label>&#x000a7;</label>Cambridge University Chemical Laboratory, MRC Centre for Protein Engineering, Lensfield Road, Cambridge CB2 1EW, United Kingdom and </aff><aff id="aff3">the <label>&#x000b6;</label>Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, Texas 77555</aff></contrib-group><author-notes><corresp id="cor1"><label>3</label> To whom correspondence should be addressed. Tel.: <phone>409-772-1309</phone>; Fax: <fax>409-747-2187</fax>; E-mail: <email>afoberha@utmb.edu</email>.</corresp><fn fn-type="present-address" id="FN3"><label>1</label><p>Present address: Structural Bioinformatics Unit, Institut Pasteur, 25&#x02013;28 Rue du Docteur Roux, Paris 75006, France.</p></fn><fn id="FN4" fn-type="other"><label>2</label><p>A Wellcome Trust Senior Research Fellow (Grant GR064417MA).</p></fn></author-notes><pub-date pub-type="ppub"><day>20</day><month>11</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>15</day><month>9</month><year>2009</year></pub-date><pub-date pub-type="pmc-release"><day>15</day><month>9</month><year>2009</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>284</volume><issue>47</issue><fpage>32942</fpage><lpage>32949</lpage><history><date date-type="received"><day>20</day><month>5</month><year>2009</year></date><date date-type="rev-recd"><day>28</day><month>8</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; 2009 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement><license license-type="open-access"><license-p><italic>Author's Choice</italic>&#x02014;Final version full access.</license-p><license-p><ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution Non-Commercial License</ext-link> applies to Author Choice Articles</license-p></license></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zbc04709032942.pdf"/><abstract><p>Mutations in polycystin-1 (PC1) can cause autosomal dominant polycystic kidney disease, which is a leading cause of renal failure. The available evidence suggests that PC1 acts as a mechanosensor, receiving signals from the primary cilia, neighboring cells, and extracellular matrix. PC1 is a large membrane protein that has a long N-terminal extracellular region (about 3000 amino acids) with a multimodular structure including 16 Ig-like polycystic kidney disease (PKD) domains, which are targeted by many naturally occurring missense mutations. Nothing is known about the effects of these mutations on the biophysical properties of PKD domains. Here we investigate the effects of several naturally occurring mutations on the mechanical stability of the first PKD domain of human PC1 (HuPKDd1). We found that several missense mutations alter the mechanical unfolding pathways of HuPKDd1, resulting in distinct mechanical phenotypes. Moreover, we found that these mutations also alter the thermodynamic stability of a structurally homologous archaeal PKD domain. Based on these findings, we hypothesize that missense mutations may cause autosomal dominant polycystic kidney disease by altering the stability of the PC1 ectodomain, thereby perturbing its ability to sense mechanical signals.</p></abstract><funding-group><award-group><funding-source id="CS100">National Institutes of Health</funding-source><award-id rid="CS100">R01DK073394</award-id></award-group></funding-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Autosomal dominant polycystic kidney disease is one of the most common life-threatening genetic diseases (with an incidence of 1 in &#x0223c;200&#x02013;1000 newborns) and is a leading cause of renal failure. The majority of cases (&#x0223c;85%) are caused by mutations in the <italic>PKD1</italic> gene, which encodes for PC1. In autosomal dominant polycystic kidney disease, the sensing mechanisms for tubule size appear to be lost, and cysts develop and enlarge progressively (<xref ref-type="bibr" rid="B1">1</xref><xref ref-type="bibr" rid="B2 B3 B4 B5 B6">&#x02013;</xref><xref ref-type="bibr" rid="B7">7</xref>). The function of PC1, as well as the mechanisms whereby mutations in this protein lead to the pathogenesis of the disease, remains unknown.</p><p>PC1 has a long extracellular domain (&#x0223c;3000 amino acids) with a multimodular structure, containing 16 copies of a &#x003b2;- sandwich fold, the polycystic kidney disease (PKD)<xref ref-type="fn" rid="FN5"><sup>4</sup></xref> domain. PKD domains have a similar topology to Ig and fibronectin type III domains found in other modular proteins with structural and mechanical roles (recently reviewed in Ref. <xref ref-type="bibr" rid="B8">8</xref>). PC1 is a membrane-associated protein that interacts with polycystin-2 (PC2) in the primary cilia of renal epithelial cells, which forms a mechanically sensitive ion channel complex. Bending of the cilia induces calcium flow into the cells, mediated by the PC1-PC2 complex (<xref ref-type="bibr" rid="B9">9</xref><xref ref-type="bibr" rid="B10">&#x02013;</xref><xref ref-type="bibr" rid="B11">11</xref>). Mechanical signals are thus transduced into cellular responses that regulate proliferation, adhesion, and differentiation, essential for the control of renal tubules and kidney morphogenesis. It has recently been shown that the extracellular domain of PC1 has a load-bearing function where most modules are designed to resist unfolding when exposed to mechanical forces (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). These data provide direct support to the hypothesis that the extracellular region is involved in the observed response of ciliated renal epithelial cells to applied forces.</p><p>To date, about 820 mutations have been identified in the PKD1 gene (available through the Autosomal Dominant Polycystic Kidney Disease: Mutation Database web site). Most are either point mutations or deletion/insertion mutations that introduce frame shifts and stop codons leading to premature termination. The most likely effect of these types of mutations is a complete loss of normal PC1 function. However, there are also about 240 missense mutations that result in non-conservative amino acid substitutions involving residues that form part of the ectodomain of PC1. Mutations may cause changes in conformation, disrupt the structure of the domains (and cause unfolding or misfolding), or affect their surface properties, as has been suggested for other Ig-like proteins (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). However, very little is known about how missense mutations might alter the structure of PC1 and mechanical properties.</p><p>In this study, we used single-molecule AFM and equilibrium thermodynamics to understand the effect of missense mutations on the mechanical properties of PC1. Six missense mutations (FH26L, T36C, G43S, W38R, R57L, and V59H) were tested on the first PKD domain of PC1, HuPKDd1. We found that these mutations alter the mechanical stability of the domain, resulting in distinct mechanical PKD phenotypes. We find that point mutations can affect the free energy of mechanical unfolding and the position of the transition state. We also found that equivalent mutations in the homologous PKD domain found in <italic>Methanosarcina</italic> archaebacteria (<xref ref-type="bibr" rid="B16">16</xref>) affect thermodynamic stability. This indicates that pathogenic mutations can affect the normal response of the PKD domain to external mechanical forces and may help understand the molecular mechanisms underlying the physiological effects of mutations in PC1.</p></sec><sec sec-type="methods"><title>EXPERIMENTAL PROCEDURES</title><sec><title/><sec><title/><sec><title>Cloning and Expression of HuPKDd1 Constructs for AFM Experiments</title><p>We cloned and expressed in bacteria a heteropolyprotein based on the first PKD domain from human PC1 (HuPKDd1, residues Val-268&#x02013;Glu-354) and the titin immunoglobulin domain 27 (I27). The I27 domain has been extensively studied by force spectroscopy and hence serves as an internal fingerprint (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>). We assembled an I27-HuPKDd1 heteropolyprotein using a multiple step cloning technique that makes use of four restriction sequences (BamHI, BglII, BstY, and KpnI) to three multiples of the I27-HuPKDd1 dimer hexamer (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). The R57L mutant heteropolyprotein was obtained by mutagenesis PCR on the I27-HuPKDd1 construct.</p><p>The single-point mutations, T36C, G43S, and V59H, were produced by PCR synthesis using the QuikChange II mutagenesis kit (Stratagene). The cDNAs were subcloned into vector pAFM1&#x02013;8 using the restriction sequences SacI and KpnI (<xref ref-type="bibr" rid="B19">19</xref>). The proteins were expressed and purified as described previously (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>) (see the <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.021832/DC1">supplemental materials</ext-link> for more details). The proteins were kept in phosphate-buffered saline containing 5 m<sc>m</sc> dithiothreitol at 4 &#x000b0;C.</p></sec><sec><title>Cloning, Expression, and Purification of Archaea PKD Domains (ArPKD)</title><p>The ArPKD monomer gene was cloned from a construct kindly supplied by S. Qamar and R. Sandford (University of Cambridge, UK) and ligated into a modified pRSETA vector (Invitrogen). Standard site-directed mutagenesis reactions were used to introduce mutations into individual domains. The proteins were expressed and purified as described previously (<xref ref-type="bibr" rid="B12">12</xref>). The two-step purification procedure involved nickel affinity chromatography followed by gel filtration.</p></sec><sec><title>Single-molecule Atomic Force Microscopy</title><p>The mechanical properties of single proteins were studied using a home-built single molecule AFM as described previously (<xref ref-type="bibr" rid="B20">20</xref><xref ref-type="bibr" rid="B21 B22 B23">&#x02013;</xref><xref ref-type="bibr" rid="B24">24</xref>). The spring constant of each individual cantilever (MLCT-AUHW: silicon nitride gold-coated cantilevers; Veeco Metrology Group, Santa Barbara, CA) was calculated using the equipartition theorem (<xref ref-type="bibr" rid="B25">25</xref>). The cantilever spring constant varied between 30 and 50 pN/nm, and root mean square force noise (1-kHz bandwidth) was &#x0223c;15 pN. Unless noted, the pulling speed of the different force-extension curves was in the range of 0.5&#x02013;0.7 nm/ms.</p></sec><sec><title>Single Protein Mechanics</title><p>In a typical experiment, a small aliquot of the purified proteins (&#x0223c;1&#x02013;50 &#x003bc;l, 10&#x02013;100 &#x003bc;g/ml) was allowed to adsorb to a clean glass coverslip (for &#x0223c;10 min) and then rinsed with phosphate-buffered saline, pH 7.4. We also tested other substrates such as nickel-nitrilotriacetic acid-coated surfaces (<xref ref-type="bibr" rid="B26">26</xref>). We found that PKD protein constructs adsorbed well to glass, gold-coated glass, or nickel-nitrilotriacetic acid-coated coverslips. We obtained identical data with these different substrates. Proteins were picked up randomly by adsorption to the cantilever tip, which was pressed down onto the sample for 1&#x02013;2 s at forces of several nanonewtons and then stretched for several hundred nanometers. The probability of picking up a protein was typically kept low (less than 1 in 50 attempts) by controlling the amount of protein used to prepare the coverslips.</p></sec><sec><title>Analysis of the Speed Dependence Data</title><p>The unfolding force distribution and speed dependence of the unfolding forces were fit using Monte Carlo simulation to calculate the unfolding rate constants, &#x003b1;<italic><sub>o</sub></italic>, and the position of the transition state, <italic>x<sub>u</sub></italic>, as described previously (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B27">27</xref><xref ref-type="bibr" rid="B28">&#x02013;</xref><xref ref-type="bibr" rid="B29">29</xref>). The errors in the determination of these parameters were estimated by running the Monte Carlo simulations about 10 times.</p></sec><sec><title>Equilibrium Denaturation of ArPKD Domains</title><p>All experiments were carried out in phosphate-buffered saline (pH 7.4) at 25 &#x000b0;C. The stability of the individual ArPKD wild-type and mutant domains was determined by urea denaturation, using standard techniques (<xref ref-type="bibr" rid="B30">30</xref>). The protein was incubated for 3 h in varying concentrations of denaturant, and unfolding was monitored by change in intrinsic fluorescence using an Aminco Bowman fluorescence spectrometer with an excitation of 280 nm and emission monitored at the wavelength of maximum emission (320 nm for W36C and 350&#x02013;360 nm for wild type and all other mutants). The raw data were fitted to a standard two-state equation, which allows [urea]<sub>50%</sub> (the concentration of denaturant where 50% of the protein is denatured) and the <italic>m</italic>-value (the dependence of &#x00394;<italic>G</italic><sub><italic>D</italic>&#x02212;<italic>N</italic></sub> on the concentration of urea) to be determined (see <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.021832/DC1">supplemental materials</ext-link>). The free energy for unfolding in 0 <sc>m</sc> denaturant (&#x00394;<italic>G</italic><sub><italic>D</italic>&#x02212;<italic>N</italic></sub><sup>H<sub>2</sub>O</sup>) can be calculated from <disp-formula id="FD1"><graphic xlink:href="zbc04709-9539-m01"/></disp-formula> where [urea]<sub>50%</sub> is the concentration of denaturant where 50% of the protein is denatured, and <italic>m</italic> is the dependence of &#x00394;<italic>G</italic><sub><italic>D</italic>&#x02212;<italic>N</italic></sub> on the concentration of urea. The PCPMer software package was used to analyze protein sequence alignments of related proteins to detect conserved physical-chemical properties (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>).</p></sec><sec><title>Determining Mutations in an Archaea PKD Domain</title><p>The solved structures of the HuPKDd1 (Protein Data Bank (PDB) code <ext-link ext-link-type="pdb" xlink:href="1B4R">1B4R</ext-link>) and the ArPKD (PDB code <ext-link ext-link-type="pdb" xlink:href="1L0Q">1L0Q</ext-link>) domain were visualized using Insight II, a commercially available program that allows structures to be manipulated and visually superimposed, and the structures were compared to determine which residues were spatially best aligned. From this alignment, it was possible to determine where to make the mutations in ArPKD that would be most nearly equivalent to those in the PC1 PKD domains.</p></sec></sec></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title/><sec><title/><sec><title>Multiple Sequence Alignment of the PC1 PKD Domains and Location of Naturally Occurring Missense Mutations</title><p>The NMR structure of the first PKD domain (HuPKDd1) shows that it has a &#x003b2;-sandwich structure with two sheets that pack together with a well defined hydrophobic core, centered around a conserved tryptophan located in the C strand (<xref ref-type="bibr" rid="B33">33</xref>). PC1 contains 16 homologous PKD domains. <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>A</italic> shows a sequence alignment of the 16 domains, together with an analysis of conserved motifs. The alignment and motif detection was done by using the PCPMer program (<xref ref-type="bibr" rid="B32">32</xref>). This program automatically detects sequence motifs defined in terms of the conserved physical-chemical properties of residues in protein families. There are six conserved motifs in PC1 PKD domains (highlighted in <italic>gray</italic>). There are about 40 missense mutations that result in non-conservative amino acid substitutions involving residues that form part of PKD domains (highlighted in <italic>cyan</italic>). Interestingly, most of these mutations (30 out of 40) are found in conserved regions.</p><fig id="F1" position="float"><label>FIGURE 1.</label><caption><p><italic>A</italic>, multiple sequence alignment of the 16 human PKD domains with structural motifs <italic>highlighted</italic>. The alignment and motif detection was done by using PCPMer program (<xref ref-type="bibr" rid="B31">31</xref>). This program automatically detects sequence motifs defined in terms of the conserved physical-chemical properties of residues in protein families. The missense mutations are highlighted in <italic>cyan</italic>, and the selected for this work are <italic>circled in red</italic>. PKD4 has additional residues in the CC&#x02032; loop. *, EQALHQFQPPYNESFPVPD. <italic>B,</italic> structure-based sequence alignment of the first human PC1 PKD domain (HuPKDd1) and archaeal PKD domain (ArPKD) and location of pathogenic mutation positions. The best aligned residues are <italic>underlined</italic>. The equivalent positions of missense mutations in both domains are highlighted (in <italic>cyan</italic>).</p></caption><graphic xlink:href="zbc0500995390001"/></fig></sec><sec><title>Selections of Missense Mutations</title><p>Of these missense mutations, we selected six (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>A</italic>, <italic>red circles</italic>) because these have been assigned as likely to be pathogenic. These are listed in <xref ref-type="table" rid="T1">Table 1</xref>. The first mutation targets PKD domain 1 where a charged amino acid (Arg) is changed to a hydrophobic amino acid (Leu); the same position in the <italic>Fugu rubripes</italic> PKD domain 1 is occupied by a basic residue (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>). The second mutation targets the conserved Trp in PKD domain 3 (changed to an Arg), which results in a pathogenic phenotype (<xref ref-type="bibr" rid="B36">36</xref>). The third mutation also occurs in PKD domain 3 and changes a polar amino acid (Gln) to His. Interestingly, the mutated glutamine is conserved in PKD domain 3 from <italic>F. rubripes</italic> to human (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B37">37</xref>). The fourth mutation is found in PKD domain 5 within the CC&#x02032; loop region. The mutation occurs within the most conserved sequence of the PKD domains, WDFGD<bold>G</bold>S (<xref ref-type="bibr" rid="B33">33</xref>). This sequence is conserved from archaea to humans (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>B</italic>). The glycine that is replaced (in bold) is in the C&#x02013;C&#x02032; turn. Its replacement by the bulkier serine is very likely to disrupt this structure (<xref ref-type="bibr" rid="B38">38</xref>). The fifth mutation is a replacement of two amino acids (Phe and Thr) to Leu. This is a large change that is likely to be pathogenic (<xref ref-type="bibr" rid="B39">39</xref>). The last mutation is found in PKD domain 16 where a Tyr is replaced by a Cys. This mutation was found to be pathogenic (<xref ref-type="bibr" rid="B40">40</xref>).</p><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p><bold>List of pathogenic missense mutations in human PC1 PKD domains and equivalent residues in HuPKDd1 and ArPKD</bold></p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Residue number</th><th align="center" rowspan="1" colspan="1">PKD domain number</th><th align="center" rowspan="1" colspan="1">Mutation position in HuPKDd1</th><th align="center" rowspan="1" colspan="1">Mutation position in ArPKD</th><th align="center" rowspan="1" colspan="1">Location strand</th><th align="center" rowspan="1" colspan="1">Surface/core</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Arg-324 &#x02192; Leu</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">R57L</td><td align="center" rowspan="1" colspan="1">T54L</td><td align="center" rowspan="1" colspan="1">E</td><td align="center" rowspan="1" colspan="1">Surface</td></tr><tr><td align="left" rowspan="1" colspan="1">Trp-967 &#x02192; Arg</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">W38R</td><td align="center" rowspan="1" colspan="1">W38R</td><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">Core</td></tr><tr><td align="left" rowspan="1" colspan="1">Gln-987 &#x02192; His</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">V59H</td><td align="center" rowspan="1" colspan="1">S56H</td><td align="center" rowspan="1" colspan="1">E&#x02013;F loop</td><td align="center" rowspan="1" colspan="1">Surface</td></tr><tr><td align="left" rowspan="1" colspan="1">Gly-1166 &#x02192; Ser</td><td align="char" char="." rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">G43S</td><td align="center" rowspan="1" colspan="1">G43S</td><td align="center" rowspan="1" colspan="1">C&#x02013;C&#x02032; loop</td><td align="center" rowspan="1" colspan="1">Short loop</td></tr><tr><td align="left" rowspan="1" colspan="1">Leu-1992, Thr-1993 &#x02192; Leu</td><td align="char" char="." rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">FH26L</td><td align="center" rowspan="1" colspan="1">FT26L</td><td align="center" rowspan="1" colspan="1">B</td><td align="center" rowspan="1" colspan="1">Surface, core</td></tr><tr><td align="left" rowspan="1" colspan="1">Tyr-2092 &#x02192; Cys</td><td align="char" char="." rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">T36C</td><td align="center" rowspan="1" colspan="1">W36C</td><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">Core</td></tr></tbody></table></table-wrap></sec><sec><title>Effect of Mutations on the Thermodynamic Stability of PKD Domains</title><p>We wanted to compare the effects of the selected point mutations on the thermodynamic stability of HuPKDd1. However, this domain is only marginally stable (&#x0223c;1&#x02013;2 kcal mol<sup>&#x02212;1</sup> (<xref ref-type="bibr" rid="B12">12</xref>)), so it is difficult to get accurate stability data. However, we have previously shown that it is possible to use homologous domains to model the effects of pathogenic mutations in Ig-like domains (<xref ref-type="bibr" rid="B15">15</xref>). The PKD domain from <italic>Methanosarcina</italic> archaebacteria (termed ArPKD) (<xref ref-type="bibr" rid="B16">16</xref>) has a very similar structure to HuPKDd1 (the two structures superimpose with an root mean square deviation of 2.2 &#x0212b; (<xref ref-type="bibr" rid="B16">16</xref>)) but is thermodynamically more stable (4.4 kcal mol<sup>&#x02212;1</sup>). ArPKD therefore presents itself as a good model system to study pathogenic mutations in PC1 PKD domains. To make equivalent mutations in the human PKD and ArPKD domains, the best approach was to examine the published structures (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B33">33</xref>) and create an alignment of the two sequences. The results of this analysis are shown in <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>B</italic>, a structure-based alignment of the ArPKD and HuPKDd1 amino acid sequences. The <italic>underlined</italic> sections of the sequence are the best aligned structurally. From this alignment, it was possible to determine where to make the mutations in ArPKD that would be most nearly equivalent to those in the PC1 PKD domains. The sites of the mutations in the aligned sequence are highlighted in <italic>cyan</italic> in <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>B</italic> and are listed in <xref ref-type="table" rid="T1">Table 1</xref>.</p><p>In equilibrium denaturation experiments, unfolding was monitored by following changes in intrinsic tryptophan fluorescence. The results are shown in <xref ref-type="fig" rid="F2">Fig. 2</xref>, and the results are summarized in <xref ref-type="table" rid="T2">Table 2</xref>. The mutants FT26L and W38R were unfolded in buffer. All point mutations destabilize the ArPKD domain to some extent.</p><fig id="F2" position="float"><label>FIGURE 2.</label><caption><p><bold>Equilibrium denaturation curves for ArPKD mutants.</bold> The effects of missense mutations T54L, S56H, G43S, and W36C on ArPKD domain stability are shown. All four mutants are made to model pathogenic mutations in HuPKDd1 domains. It is clear from the changes in the midpoint that both W36C and G43S destabilize the domain significantly, whereas the mutations T54L and S56H have little effect on the stability of the PKD domain.</p></caption><graphic xlink:href="zbc0500995390002"/></fig><table-wrap id="T2" position="float"><label>TABLE 2</label><caption><p><bold>Thermodynamic stabilities of ArPKD mutants</bold></p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Mutation position in ArPKD</th><th align="center" rowspan="1" colspan="1"><italic>m-</italic>value</th><th align="center" rowspan="1" colspan="1">[urea]<sub>50%</sub> ArPKD</th><th align="center" rowspan="1" colspan="1">&#x00394;<italic>G</italic><sub><italic>D</italic>&#x02212;<italic>N</italic></sub><sup>H<sub>2</sub>O</sup> ArPKD<xref ref-type="table-fn" rid="TF2-1"><sup><italic>a</italic></sup></xref></th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>kcal mol</italic><sup>&#x02212;1</sup><sc>m</sc><sup>&#x02212;1</sup></td><td align="center" rowspan="1" colspan="1"><sc>m</sc></td><td align="center" rowspan="1" colspan="1">kcal mol<sup>&#x02212;1</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Wild type</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1.0 &#x000b1; 0.1</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">4.4 &#x000b1; 0.1</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">4.4 &#x000b1; 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1">T54L</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1.0 &#x000b1; 0.1</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">4.1 &#x000b1; 0.1</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">4.1 &#x000b1; 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1">W38R</td><td align="center" rowspan="1" colspan="1">Unfolded</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">S56H</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">0.9 &#x000b1; 0.1</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">4.5 &#x000b1; 0.1</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">4.1 &#x000b1; 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1">G43S</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1.0 &#x000b1; 0.1</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2.6 &#x000b1; 0.1</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2.6 &#x000b1; 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1">FT26L</td><td align="center" rowspan="1" colspan="1">Unfolded</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">W36C</td><td align="char" char="." rowspan="1" colspan="1">1.0<xref ref-type="table-fn" rid="TF2-1"><sup><italic>a</italic></sup></xref></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1.9 &#x000b1; 0.1</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1.9 &#x000b1; 0.1</td></tr></tbody></table><table-wrap-foot><fn id="TF2-1"><p><italic><sup>a</sup></italic> Because W36C was so destabilized that there was no true folded baseline, the data were fitted with <italic>m</italic> fixed to the wild-type value of 1.0.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Effects of the Missense Mutations on the Mechanical Stability of HuPKDd1</title><p>To study the effect of missense mutations on the mechanical stability of PKD domains, we used HuPKDd1 as a template because its structure is known (<xref ref-type="bibr" rid="B33">33</xref>) and its thermodynamic and mechanical stabilities have been characterized (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). To make equivalent mutations in the HuPKDd1 domain, we used the sequence alignment shown in <xref ref-type="fig" rid="F1">Fig. 1</xref> and mutated the equivalent residues using site-directed mutagenesis. The locations of the different residues mutated in HuPKDd1 are shown in <xref ref-type="fig" rid="F3">Fig. 3</xref>. For example, the change of Val-59 to His in HuPKDd1 corresponds to the natural mutation Gln-987 to His in PKD domain 3.</p><fig id="F3" position="float"><label>FIGURE 3.</label><caption><p><bold>NMR structure of HuPKDd1 showing the positions of mutated residues.</bold> The figure was prepared using the program PyMOL.</p></caption><graphic xlink:href="zbc0500995390003"/></fig><p>We used a heteropolyprotein approach to study the mechanical properties of mutant HuPKDd1 domains using single-molecule AFM techniques. In these constructs, we used the titin domain I27 as an internal mechanical fingerprint that has been extensively studied with AFM techniques (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B41">41</xref>). Also, I27-based protein chimeras have been found to express well in bacteria; this strategy has proven to be useful in the analysis of several protein domains with single molecule AFM (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>).</p><p><xref ref-type="fig" rid="F4">Fig. 4</xref> shows typical examples of force-extension curves obtained for I27 heteropolyproteins harboring the wild-type and mutant HuPKDd1. As shown before, the wild-type HuPKDd1 has a mechanical stability very similar to I27 domains and unfolds at forces of about 180 pN (<xref ref-type="fig" rid="F4">Fig. 4</xref><italic>F</italic>) (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). <xref ref-type="fig" rid="F3">Fig. 3</xref>, <italic>B&#x02013;E</italic>, show that missense mutations R57L, V59H, G43S, and T36C all result in a significant decrease in the mechanical stability. For example, the R57L mutant domain unfolds at forces of &#x0223c;140 pN (<xref ref-type="fig" rid="F4">Fig. 4</xref><italic>G</italic>), which is seen as the force peaks (marked in <xref ref-type="fig" rid="F4">Fig. 4</xref><italic>B</italic> by the <italic>dashed line</italic>) preceding the unfolding of the I27 domains (they unfold at &#x0223c;180 pN). The G43S mutation has a strong destabilizing effect of HuPKDd1. This mutant domain unfolds at &#x0223c;55 pN, which is seen as a small force peak (marked by the <italic>arrow</italic>) preceding the unfolding of the I27 domains (<xref ref-type="fig" rid="F4">Fig. 4</xref><italic>D</italic>). We found that the W38R and FT26L mutations severely destabilize the PKD domain because we were not able to express these constructs as soluble proteins.</p><fig id="F4" position="float"><label>FIGURE 4.</label><caption><p><bold>Force-extension relationships for wild-type (<italic>wt</italic>) and mutant HuPKDd1 measured with AFM techniques.</bold> Stretching a single molecule of each construct gave force-extension curves that followed a saw-tooth pattern with equally spaced force peaks. The schematic above each recording shows the construction of each recombinant protein chimera. The wild-type HuPKDd1 and the R57L mutant were constructed by repeating the I27-HuPKDd1 three times. The T36C, G43S, and V59H HuPKDd1 mutants were flanked by several I27 domains (to increase the solubility of expressed protein). The <italic>dashed lines</italic> in <italic>A</italic> and <italic>B</italic> present the average force used to unfold either wild-type or R57L mutant HuPKDd1. The force peaks pointed to by the <italic>solid arrow</italic> represent the unfolding of mutant domains of V59H (<italic>C</italic>), G43S (<italic>D</italic>), and T36C (<italic>E</italic>). The forces used to unfold the wild-type and mutated HuPKDd1 are shown as force histograms (<italic>F&#x02013;J</italic>). The force peaks of wild-type PKD had an average force of 176 &#x000b1; 32 pN (<italic>n</italic> = 189). The average forces for unfolding the HuPKDd1 mutants are: 143 &#x000b1; 34 pN (<italic>n</italic> = 50) for R57L, 127 &#x000b1; 33 pN (<italic>n</italic> = 59) for V59H, 54 &#x000b1; 15 pN (<italic>n</italic> = 46) for G43S, and 79 &#x000b1; 20 pN (<italic>n</italic> = 129) for T36C. All the experiments were carried out at the pulling speed of 0.4&#x02013;0.6 nm/ms.</p></caption><graphic xlink:href="zbc0500995390004"/></fig></sec><sec><title>Kinetics of Unfolding of HuPKDd1 Mutants</title><p>To quantify the effect of the missense mutations on the kinetics of unfolding, we analyzed the effect of pulling speed on the unfolding forces. <xref ref-type="fig" rid="F5">Fig. 5</xref> shows a plot of the average unfolding force <italic>versus</italic> the pulling rate for wild type and different mutants. The parameters used for the Monte Carlo simulation are shown in <xref ref-type="table" rid="T3">Table 3</xref>. The unfolding rate constants, &#x003b1;<italic><sub>o</sub></italic>, of the four mutants are higher than that of the wild type (9.8 &#x000d7; 10<sup>&#x02212;4</sup> s<sup>&#x02212;1</sup>), indicating that the activation energy of unfolding was decreased by the mutations. The unfolding distances to the transition state, <italic>x<sub>u</sub></italic>, of the G43S and T36C mutants are also larger than the wild type, indicating that there is a significant change in the unfolding pathway.</p><fig id="F5" position="float"><label>FIGURE 5.</label><caption><p><bold>Kinetics of unfolding of HuPKDd1 mutants.</bold> A plot of the average unfolding force <italic>versus</italic> the pulling rate for wild-type (<italic>wt</italic>, <italic>black squares</italic>), R57L (<italic>cyan circles</italic>), V59H (<italic>green triangles</italic>), T36C (<italic>red squares</italic>), and G43S (<italic>blue circles</italic>) HuPKDd1 domains is shown. The <italic>solid lines</italic> are fits of the Monte Carlo simulation to the experimental data (see &#x0201c;Experimental Procedures&#x0201d;). The parameters used for the Monte Carlo simulation are shown in <xref ref-type="table" rid="T3">Table 3</xref>.</p></caption><graphic xlink:href="zbc0500995390005"/></fig><table-wrap id="T3" position="float"><label>TABLE 3</label><caption><p><bold>Estimated mechanical kinetic parameters of HuPKDd1 mutants</bold></p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">F<sub>u</sub><xref ref-type="table-fn" rid="TF3-1"><sup><italic>a</italic></sup></xref></th><th align="center" rowspan="1" colspan="1">&#x003b1;<italic><sub>o</sub></italic></th><th align="center" rowspan="1" colspan="1"><italic>x<sub>u</sub></italic></th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>pN</italic></td><td align="center" rowspan="1" colspan="1"><italic>s</italic><sup>&#x02212;<italic>1</italic></sup></td><td align="center" rowspan="1" colspan="1"><italic>nm</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Wild type</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">176 &#x000b1; 32</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">9.8 &#x000b1; 8.1 &#x000d7; 10<sup>&#x02212;4</sup></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">0.25 &#x000b1; 0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">R57L</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">143 &#x000b1; 34</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2.6 &#x000b1; 1.8 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">0.24 &#x000b1; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">V59H</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">127 &#x000b1; 33</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">6.9 &#x000b1; 5.3 &#x000d7; 10<sup>&#x02212;2</sup></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">0.22 &#x000b1; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">G43S</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">54 &#x000b1; 15</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2.3 &#x000b1; 1.8 &#x000d7; 10<sup>&#x02212;1</sup></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">0.31 &#x000b1; 0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">T36C</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">79 &#x000b1; 20</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">0.7 &#x000b1; 0.5 &#x000d7; 10<sup>&#x02212;1</sup></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">0.32 &#x000b1; 0.02</td></tr></tbody></table><table-wrap-foot><fn id="TF3-1"><p><italic><sup>a</sup></italic> At pulling speed of 0.4&#x02013;0.6 nm ms<sup>&#x02212;1</sup>.</p></fn></table-wrap-foot></table-wrap></sec></sec></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>We are using HuPKDd1 as a model system for assessing the effects of mutation on the mechanical stability of PKD domains in general. In general, we found that all the mutations resulted in a loss in mechanical stability. A number of studies have demonstrated that homologous proteins have the same unfolding pathways on application of force, <italic>i.e.</italic> the same mechanisms for resisting forced unfolding. Using a combination of simulations and experiments, we have recently shown that the same is true of HuPKDd1 and ArPKD.<xref ref-type="fn" rid="FN6"><sup>5</sup></xref> Hence, mutations that promote mechanical unfolding in HuPKDd1 are likely to have the same effect in other PKD domains.</p><sec><title/><sec><title/><sec><title>All the Mutations Destabilize HuPKD and ArPKD Domains to Some Extent</title><p><xref ref-type="table" rid="T4">Table 4</xref> shows a summary of the effects of missense mutations on HuPKDd1 and ArPKD.</p><table-wrap id="T4" position="float"><label>TABLE 4</label><caption><p><bold>Comparison of the effect of mutations on thermodynamic and mechanical stability of PKD domains</bold></p><p>NA, not applicable.</p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Mutation position in HuPKDd1</th><th align="center" rowspan="1" colspan="1">Mutation position in ArPKD</th><th align="center" rowspan="1" colspan="1">&#x00394;<italic>G</italic><sub><italic>D</italic>&#x02212;<italic>N</italic></sub><sup>H<sub>2</sub>O</sup> ArPKD</th><th align="center" rowspan="1" colspan="1">&#x00394;F<sub>u</sub> HuPKDd1</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>kcal mol</italic><sup>&#x02212;<italic>1</italic></sup></td><td align="center" rowspan="1" colspan="1"><italic>pN</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Wild type</td><td align="center" rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">R57L</td><td align="center" rowspan="1" colspan="1">T54L</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">0.3 &#x000b1; 0.1</td><td align="char" char="." rowspan="1" colspan="1">33</td></tr><tr><td align="left" rowspan="1" colspan="1">W38R</td><td align="center" rowspan="1" colspan="1">W38R</td><td align="char" char="." rowspan="1" colspan="1">&#x0003e;4.4</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">V59H</td><td align="center" rowspan="1" colspan="1">S56H</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">0.3 &#x000b1; 0.1</td><td align="char" char="." rowspan="1" colspan="1">49</td></tr><tr><td align="left" rowspan="1" colspan="1">G43S</td><td align="center" rowspan="1" colspan="1">G43S</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1.8 &#x000b1; 0.1</td><td align="char" char="." rowspan="1" colspan="1">122</td></tr><tr><td align="left" rowspan="1" colspan="1">FH26L</td><td align="center" rowspan="1" colspan="1">FT26L</td><td align="char" char="." rowspan="1" colspan="1">&#x0003e;4.4</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">T36C</td><td align="center" rowspan="1" colspan="1">W36C</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2.5 &#x000b1; 0.1</td><td align="char" char="." rowspan="1" colspan="1">97</td></tr></tbody></table></table-wrap></sec><sec><title>Unfolded Mutants</title><p>The FH26L (or FT26L in ArPKD) and W38R mutations result in an unfolded protein domain. This is not unexpected because these target large buried residues. In particular, the Trp to Arg mutation, introducing a charged group into a buried position, causes a drastic reduction in stability. Furthermore, the tryptophan in that position is very highly conserved across the PKD domains, suggesting that it may have an importance for folding. Hence, for the W38R and FH26L, it seems very likely that the presence of the unfolded domain causes the observed disease phenotype. Perhaps the destabilized ectodomain of PC1 cannot perform its mechanosensing function, or perhaps the presence of the unfolded domain causes the protein to aggregate, to fail to be trafficked correctly, or to be degraded by the normal cell degradation machinery.</p></sec><sec><title>Destabilizing Mutations</title><p>Mutation T36C (or W36C in ArPKD) to cysteine replaces a large surface aromatic with a small polar side chain. This is a position with a high degree of conservation in the PKD domains. Of the other 16 PKD domains, eight have a tyrosine and four have a phenylalanine at the equivalent position, all large aromatic side chains. Rossetti <italic>et al.</italic> (<xref ref-type="bibr" rid="B44">44</xref>) note that this residue is conserved in the C strand of many PKD domains, including in the mouse gene, but interestingly, in <italic>F. rubripes</italic>, there is a cysteine at the equivalent position. The G43S replaces a glycine with a serine in a loop region of the protein structure. This results in a significant destabilization. This destabilization might be expected, given the conservation in this region of the structure in PKD domains of polycystin. Interestingly, this glycine residue occupies a region &#x003d5;/&#x003c8; space of the Ramachandran plot (<xref ref-type="bibr" rid="B45">45</xref>), which is disallowed for residues other than glycine (positive &#x003d5;, negative &#x003c8;) in the structures of both ArPKD and HuPKDd1.</p><p>The T36C and G43S mutants had a very significant effect on the ability of HuPKDd1 to resist forced unfolding. The unfolding force is significantly lower in these mutants, and furthermore, the distance to the transition state (<italic>x<sub>u</sub></italic>) is significantly larger for each of these mutants, suggesting that the unfolding pathway changes significantly. Such a change in <italic>x<sub>u</sub></italic>, associated with a change in folding mechanism, has been observed for mutants of I27 domain from human titin (<xref ref-type="bibr" rid="B29">29</xref>). We conclude that mutations in these positions might potentially have a significant effect on the mechanical function of PC1.</p></sec><sec><title>Slightly Destabilizing Mutations</title><p>The mutations that are only slightly destabilizing, R57L and V59H (T54L and S56H in ArPKD), are surface mutations. This suggests that these mutations are in regions of the protein that are not important for the mechanical stability of the PKD domains. Thomas <italic>et al.</italic> (<xref ref-type="bibr" rid="B35">35</xref>) reported the R57L mutation. They note the change from a basic to neutral hydrophobic residue and report that this is the only PKD domain with a basic residue in this position. Furthermore, a basic residue is found in the equivalent position in <italic>F. rubripes</italic>. Due to this conservation, they suggest that this residue may be functionally important, for example, in ligand binding or protein-protein interactions (<xref ref-type="bibr" rid="B35">35</xref>). Our results do not suggest that this is a position that is critical for the mechanical stability of PKD domains.</p><p>Our data suggest that the effect of the mutations G43S, T36C, and in particular, W38R and FH26L are likely to be mainly due to the large destabilization these mutations confer on the parent PKD domain (<italic>i.e.</italic> G1166S, Y2092C, W967R, and F1992L, T1993L, respectively). They will also, therefore, compromise the ability of PC1 to act as a mechanosensor.</p><p>In time, it may be possible to analyze naturally occurring variations in the genome sequence, predict the biophysical effect of the mutation, and estimate the likelihood of a given variation to be deleterious or benign. As seen here, such studies could also suggest further research into protein function, and possibly, mutation-specific therapies. There is increasing interest in human protein mutations, particularly naturally occurring mutations that may be disease-related. Although many of these proteins are experimentally intractable, the strategy presented here could make mutation studies in many human proteins possible for the first time.</p></sec></sec></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="PMC_1" content-type="local-data"><caption><title>Supplemental Data</title></caption><media mimetype="text" mime-subtype="html" xlink:href="supp_284_47_32942__index.html"/><media xlink:role="associated-file" mimetype="application" mime-subtype="msword" xlink:href="supp_M109.021832_jbc.M109.021832-1.doc"/></supplementary-material></sec></body><back><fn-group><fn fn-type="supported-by" id="FN1"><label>*</label><p>This work was supported, in whole or in part, by National Institutes of Health Grant R01DK073394 (to A. F. O.). This work was also supported by grants from the John Sealy Memorial Endowment Fund for Biomedical Research and the Polycystic Kidney Foundation (Grant 116a2r).</p></fn><fn fn-type="supplementary-material" id="FN2"><label><inline-graphic xlink:href="sbox.jpg"/></label><p>The on-line version of this article (available at <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org">http://www.jbc.org</ext-link>) contains <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.021832/DC1">supplemental Figs. 1 and 2</ext-link>.</p></fn><fn fn-type="other" id="FN6"><label>5</label><p> J. R. Forman, J. Clarke, and E. Paci, unpublished data.</p></fn></fn-group><fn-group content-type="abbreviations"><fn id="FN5"><label>4</label><p>The abbreviations used are: <def-list><def-item><term id="G1">PKD</term><def><p>polycystic kidney disease domain</p></def></def-item><def-item><term id="G2">ArPKD</term><def><p>archaea PKD domain</p></def></def-item><def-item><term id="G3">HuPKDd1</term><def><p>first human PC1 PKD domain</p></def></def-item><def-item><term id="G4">AFM</term><def><p>atomic force microscopy</p></def></def-item><def-item><term id="G5">pN</term><def><p>piconewtons.</p></def></def-item></def-list></p></fn></fn-group><ack><title>Acknowledgment</title><p>We thank Jiping Wang (University of Texas Medical Branch) for helping with the expression and purification of some of the HuPKDd1 mutant proteins used in <xref ref-type="fig" rid="F4">Fig. 4</xref>.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabow</surname><given-names>P. A.</given-names></name></person-group> (<year>1990</year>) <source>Am. J. Kidney Dis.</source><volume>16</volume>, <fpage>403</fpage>&#x02013;<lpage>413</lpage><pub-id pub-id-type="pmid">2239929</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>G.</given-names></name><name><surname>Somlo</surname><given-names>S.</given-names></name></person-group> (<year>2000</year>) <source>Mol. Genet. Metab.</source><volume>69</volume>, <fpage>1</fpage>&#x02013;<lpage>15</lpage><pub-id pub-id-type="pmid">10655152</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>V. E.</given-names></name><name><surname>Harris</surname><given-names>P. C.</given-names></name></person-group> (<year>2006</year>) <source>Nat. Clin. Pract. Nephrol.</source><volume>2</volume>, <fpage>40</fpage>&#x02013;<lpage>55</lpage><pub-id pub-id-type="pmid">16932388</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>P. C.</given-names></name><name><surname>Torres</surname><given-names>V. E.</given-names></name></person-group> (<year>2009</year>) <source>Annu. Rev. Med.</source><volume>60</volume>, <fpage>321</fpage>&#x02013;<lpage>337</lpage><pub-id pub-id-type="pmid">18947299</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaletta</surname><given-names>T.</given-names></name><name><surname>Van der Craen</surname><given-names>M.</given-names></name><name><surname>Van Geel</surname><given-names>A.</given-names></name><name><surname>Dewulf</surname><given-names>N.</given-names></name><name><surname>Bogaert</surname><given-names>T.</given-names></name><name><surname>Branden</surname><given-names>M.</given-names></name><name><surname>King</surname><given-names>K. V.</given-names></name><name><surname>Buechner</surname><given-names>M.</given-names></name><name><surname>Barstead</surname><given-names>R.</given-names></name><name><surname>Hyink</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>H. P.</given-names></name><name><surname>Geng</surname><given-names>L.</given-names></name><name><surname>Burrow</surname><given-names>C.</given-names></name><name><surname>Wilson</surname><given-names>P.</given-names></name></person-group> (<year>2003</year>) <source>Nephron Exp. Nephrol.</source><volume>93</volume>, <fpage>e9</fpage>&#x02013;<lpage>17</lpage><pub-id pub-id-type="pmid">12411744</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>P. D.</given-names></name></person-group> (<year>2004</year>) <source>Int. J. Biochem. Cell Biol.</source><volume>36</volume>, <fpage>1868</fpage>&#x02013;<lpage>1873</lpage><pub-id pub-id-type="pmid">15203099</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutters</surname><given-names>M.</given-names></name><name><surname>Germino</surname><given-names>G. G.</given-names></name></person-group> (<year>2003</year>) <source>J. Lab. Clin. Med.</source><volume>141</volume>, <fpage>91</fpage>&#x02013;<lpage>101</lpage><pub-id pub-id-type="pmid">12577044</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oberhauser</surname><given-names>A. F.</given-names></name><name><surname>Carri&#x000f3;n-V&#x000e1;zquez</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>) <source>J. Biol. Chem.</source><volume>283</volume>, <fpage>6617</fpage>&#x02013;<lpage>6621</lpage><pub-id pub-id-type="pmid">18195002</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nauli</surname><given-names>S. M.</given-names></name><name><surname>Alenghat</surname><given-names>F. J.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Williams</surname><given-names>E.</given-names></name><name><surname>Vassilev</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Elia</surname><given-names>A. E.</given-names></name><name><surname>Lu</surname><given-names>W.</given-names></name><name><surname>Brown</surname><given-names>E. M.</given-names></name><name><surname>Quinn</surname><given-names>S. J.</given-names></name><name><surname>Ingber</surname><given-names>D. E.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name></person-group> (<year>2003</year>) <source>Nat. Genet.</source><volume>33</volume>, <fpage>129</fpage>&#x02013;<lpage>137</lpage><pub-id pub-id-type="pmid">12514735</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alenghat</surname><given-names>F. J.</given-names></name><name><surname>Nauli</surname><given-names>S. M.</given-names></name><name><surname>Kolb</surname><given-names>R.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Ingber</surname><given-names>D. E.</given-names></name></person-group> (<year>2004</year>) <source>Exp. Cell Res.</source><volume>301</volume>, <fpage>23</fpage>&#x02013;<lpage>30</lpage><pub-id pub-id-type="pmid">15501441</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nauli</surname><given-names>S. M.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>) <source>BioEssays</source><volume>26</volume>, <fpage>844</fpage>&#x02013;<lpage>856</lpage><pub-id pub-id-type="pmid">15273987</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forman</surname><given-names>J. R.</given-names></name><name><surname>Qamar</surname><given-names>S.</given-names></name><name><surname>Paci</surname><given-names>E.</given-names></name><name><surname>Sandford</surname><given-names>R. N.</given-names></name><name><surname>Clarke</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>) <source>J. Mol. Biol.</source><volume>349</volume>, <fpage>861</fpage>&#x02013;<lpage>871</lpage><pub-id pub-id-type="pmid">15894330</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>F.</given-names></name><name><surname>Wei</surname><given-names>W.</given-names></name><name><surname>Germino</surname><given-names>G.</given-names></name><name><surname>Oberhauser</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>) <source>J. Biol. Chem.</source><volume>280</volume>, <fpage>40723</fpage>&#x02013;<lpage>40730</lpage><pub-id pub-id-type="pmid">16219758</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bateman</surname><given-names>A.</given-names></name><name><surname>Jouet</surname><given-names>M.</given-names></name><name><surname>MacFarlane</surname><given-names>J.</given-names></name><name><surname>Du</surname><given-names>J. S.</given-names></name><name><surname>Kenwrick</surname><given-names>S.</given-names></name><name><surname>Chothia</surname><given-names>C.</given-names></name></person-group> (<year>1996</year>) <source>EMBO J.</source><volume>15</volume>, <fpage>6050</fpage>&#x02013;<lpage>6059</lpage><pub-id pub-id-type="pmid">8947027</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randles</surname><given-names>L. G.</given-names></name><name><surname>Lappalainen</surname><given-names>I.</given-names></name><name><surname>Fowler</surname><given-names>S. B.</given-names></name><name><surname>Moore</surname><given-names>B.</given-names></name><name><surname>Hamill</surname><given-names>S. J.</given-names></name><name><surname>Clarke</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>) <source>J. Biol. Chem.</source><volume>281</volume>, <fpage>24216</fpage>&#x02013;<lpage>24226</lpage><pub-id pub-id-type="pmid">16760466</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jing</surname><given-names>H.</given-names></name><name><surname>Takagi</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>J. H.</given-names></name><name><surname>Lindgren</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>R. G.</given-names></name><name><surname>Joachimiak</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>J. H.</given-names></name><name><surname>Springer</surname><given-names>T. A.</given-names></name></person-group> (<year>2002</year>) <source>Structure</source><volume>10</volume>, <fpage>1453</fpage>&#x02013;<lpage>1464</lpage><pub-id pub-id-type="pmid">12377130</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Best</surname><given-names>R. B.</given-names></name><name><surname>Fowler</surname><given-names>S. B.</given-names></name><name><surname>Toca-Herrera</surname><given-names>J. L.</given-names></name><name><surname>Clarke</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>) <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>99</volume>, <fpage>12143</fpage>&#x02013;<lpage>12148</lpage><pub-id pub-id-type="pmid">12218181</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Best</surname><given-names>R. B.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Steward</surname><given-names>A.</given-names></name><name><surname>Daggett</surname><given-names>V.</given-names></name><name><surname>Clarke</surname><given-names>J.</given-names></name></person-group> (<year>2001</year>) <source>Biophys. J.</source><volume>81</volume>, <fpage>2344</fpage>&#x02013;<lpage>2356</lpage><pub-id pub-id-type="pmid">11566804</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steward</surname><given-names>A.</given-names></name><name><surname>Toca-Herrera</surname><given-names>J. L.</given-names></name><name><surname>Clarke</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>) <source>Protein Sci.</source><volume>11</volume>, <fpage>2179</fpage>&#x02013;<lpage>2183</lpage><pub-id pub-id-type="pmid">12192073</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bullard</surname><given-names>B.</given-names></name><name><surname>Linke</surname><given-names>W. A.</given-names></name><name><surname>Leonard</surname><given-names>K.</given-names></name></person-group> (<year>2002</year>) <source>J. Muscle Res. Cell Motil.</source><volume>23</volume>, <fpage>435</fpage>&#x02013;<lpage>447</lpage><pub-id pub-id-type="pmid">12785095</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrion-Vazquez</surname><given-names>M.</given-names></name><name><surname>Oberhauser</surname><given-names>A. F.</given-names></name><name><surname>Fowler</surname><given-names>S. B.</given-names></name><name><surname>Marszalek</surname><given-names>P. E.</given-names></name><name><surname>Broedel</surname><given-names>S. E.</given-names></name><name><surname>Clarke</surname><given-names>J.</given-names></name><name><surname>Fernandez</surname><given-names>J. M.</given-names></name></person-group> (<year>1999</year>) <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>96</volume>, <fpage>3694</fpage>&#x02013;<lpage>3699</lpage><pub-id pub-id-type="pmid">10097099</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>E.</given-names></name><name><surname>Garcia</surname><given-names>T.</given-names></name><name><surname>Hultgren</surname><given-names>S.</given-names></name><name><surname>Oberhauser</surname><given-names>A. F.</given-names></name></person-group> (<year>2006</year>) <source>Biophys. J</source><volume>91</volume>, <fpage>3848</fpage>&#x02013;<lpage>3856</lpage><pub-id pub-id-type="pmid">16950852</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oberhauser</surname><given-names>A. F.</given-names></name><name><surname>Badilla-Fernandez</surname><given-names>C.</given-names></name><name><surname>Carrion-Vazquez</surname><given-names>M.</given-names></name><name><surname>Fernandez</surname><given-names>J. M.</given-names></name></person-group> (<year>2002</year>) <source>J. Mol. Biol.</source><volume>319</volume>, <fpage>433</fpage>&#x02013;<lpage>447</lpage><pub-id pub-id-type="pmid">12051919</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oberhauser</surname><given-names>A. F.</given-names></name><name><surname>Marszalek</surname><given-names>P. E.</given-names></name><name><surname>Erickson</surname><given-names>H. P.</given-names></name><name><surname>Fernandez</surname><given-names>J. M.</given-names></name></person-group> (<year>1998</year>) <source>Nature</source><volume>393</volume>, <fpage>181</fpage>&#x02013;<lpage>185</lpage><pub-id pub-id-type="pmid">9603523</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florin</surname><given-names>E. L.</given-names></name><name><surname>Rief</surname><given-names>M.</given-names></name><name><surname>Lehmann</surname><given-names>T.</given-names></name><name><surname>Ludvig</surname><given-names>M.</given-names></name><name><surname>Dornmair</surname><given-names>C.</given-names></name><name><surname>Moy</surname><given-names>V. T.</given-names></name><name><surname>Gaub</surname><given-names>H. E.</given-names></name></person-group> (<year>1995</year>) <source>Biosens. Bioelectron.</source><volume>10</volume>, <fpage>895</fpage>&#x02013;<lpage>901</lpage></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>D. C.</given-names></name><name><surname>Stroh</surname><given-names>C. M.</given-names></name><name><surname>Jensenius</surname><given-names>H.</given-names></name><name><surname>van Es</surname><given-names>M.</given-names></name><name><surname>Kamruzzahan</surname><given-names>A. S.</given-names></name><name><surname>Stamouli</surname><given-names>A.</given-names></name><name><surname>Gruber</surname><given-names>H. J.</given-names></name><name><surname>Oosterkamp</surname><given-names>T. H.</given-names></name><name><surname>Hinterdorfer</surname><given-names>P.</given-names></name></person-group> (<year>2003</year>) <source>Chemphyschem.</source><volume>4</volume>, <fpage>1367</fpage>&#x02013;<lpage>1371</lpage><pub-id pub-id-type="pmid">14714391</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oberhauser</surname><given-names>A. F.</given-names></name><name><surname>Hansma</surname><given-names>P. K.</given-names></name><name><surname>Carrion-Vazquez</surname><given-names>M.</given-names></name><name><surname>Fernandez</surname><given-names>J. M.</given-names></name></person-group> (<year>2001</year>) <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>98</volume>, <fpage>468</fpage>&#x02013;<lpage>472</lpage><pub-id pub-id-type="pmid">11149943</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rief</surname><given-names>M.</given-names></name><name><surname>Gautel</surname><given-names>M.</given-names></name><name><surname>Oesterhelt</surname><given-names>F.</given-names></name><name><surname>Fernandez</surname><given-names>J. M.</given-names></name><name><surname>Gaub</surname><given-names>H. E.</given-names></name></person-group> (<year>1997</year>) <source>Science</source><volume>276</volume>, <fpage>1109</fpage>&#x02013;<lpage>1112</lpage><pub-id pub-id-type="pmid">9148804</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Carrion-Vazquez</surname><given-names>M.</given-names></name><name><surname>Oberhauser</surname><given-names>A. F.</given-names></name><name><surname>Marszalek</surname><given-names>P. E.</given-names></name><name><surname>Fernandez</surname><given-names>J. M.</given-names></name></person-group> (<year>2000</year>) <source>Nat. Struct. Biol.</source><volume>7</volume>, <fpage>1117</fpage>&#x02013;<lpage>1120</lpage><pub-id pub-id-type="pmid">11101892</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pace</surname><given-names>C. N.</given-names></name></person-group> (<year>1986</year>) <source>Methods Enzymol.</source><volume>131</volume>, <fpage>266</fpage>&#x02013;<lpage>280</lpage><pub-id pub-id-type="pmid">3773761</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathura</surname><given-names>V. S.</given-names></name><name><surname>Schein</surname><given-names>C. H.</given-names></name><name><surname>Braun</surname><given-names>W.</given-names></name></person-group> (<year>2003</year>) <source>Bioinformatics</source><volume>19</volume>, <fpage>1381</fpage>&#x02013;<lpage>1390</lpage><pub-id pub-id-type="pmid">12874050</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>T. I.</given-names></name><name><surname>Oberhauser</surname><given-names>A. F.</given-names></name><name><surname>Braun</surname><given-names>W.</given-names></name></person-group> (<year>2009</year>) <source>Proteins</source><volume>75</volume>, <fpage>706</fpage>&#x02013;<lpage>718</lpage><pub-id pub-id-type="pmid">19003986</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bycroft</surname><given-names>M.</given-names></name><name><surname>Bateman</surname><given-names>A.</given-names></name><name><surname>Clarke</surname><given-names>J.</given-names></name><name><surname>Hamill</surname><given-names>S. J.</given-names></name><name><surname>Sandford</surname><given-names>R.</given-names></name><name><surname>Thomas</surname><given-names>R. L.</given-names></name><name><surname>Chothia</surname><given-names>C.</given-names></name></person-group> (<year>1999</year>) <source>EMBO J.</source><volume>18</volume>, <fpage>297</fpage>&#x02013;<lpage>305</lpage><pub-id pub-id-type="pmid">9889186</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandford</surname><given-names>R.</given-names></name><name><surname>Sgotto</surname><given-names>B.</given-names></name><name><surname>Aparicio</surname><given-names>S.</given-names></name><name><surname>Brenner</surname><given-names>S.</given-names></name><name><surname>Vaudin</surname><given-names>M.</given-names></name><name><surname>Wilson</surname><given-names>R. K.</given-names></name><name><surname>Chissoe</surname><given-names>S.</given-names></name><name><surname>Pepin</surname><given-names>K.</given-names></name><name><surname>Bateman</surname><given-names>A.</given-names></name><name><surname>Chothia</surname><given-names>C.</given-names></name><name><surname>Hughes</surname><given-names>J.</given-names></name><name><surname>Harris</surname><given-names>P.</given-names></name></person-group> (<year>1997</year>) <source>Hum. Mol. Genet.</source><volume>6</volume>, <fpage>1483</fpage>&#x02013;<lpage>1489</lpage><pub-id pub-id-type="pmid">9285785</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>R.</given-names></name><name><surname>McConnell</surname><given-names>R.</given-names></name><name><surname>Whittacker</surname><given-names>J.</given-names></name><name><surname>Kirkpatrick</surname><given-names>P.</given-names></name><name><surname>Bradley</surname><given-names>J.</given-names></name><name><surname>Sandford</surname><given-names>R.</given-names></name></person-group> (<year>1999</year>) <source>Am. J. Hum. Genet.</source><volume>65</volume>, <fpage>39</fpage>&#x02013;<lpage>49</lpage><pub-id pub-id-type="pmid">10364515</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossetti</surname><given-names>S.</given-names></name><name><surname>Consugar</surname><given-names>M. B.</given-names></name><name><surname>Chapman</surname><given-names>A. B.</given-names></name><name><surname>Torres</surname><given-names>V. E.</given-names></name><name><surname>Guay-Woodford</surname><given-names>L. M.</given-names></name><name><surname>Grantham</surname><given-names>J. J.</given-names></name><name><surname>Bennett</surname><given-names>W. M.</given-names></name><name><surname>Meyers</surname><given-names>C. M.</given-names></name><name><surname>Walker</surname><given-names>D. L.</given-names></name><name><surname>Bae</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>Q. J.</given-names></name><name><surname>Thompson</surname><given-names>P. A.</given-names></name><name><surname>Miller</surname><given-names>J. P.</given-names></name><name><surname>Harris</surname><given-names>P. C.</given-names></name></person-group> (<year>2007</year>) <source>J. Am. Soc. Nephrol.</source><volume>18</volume>, <fpage>2143</fpage>&#x02013;<lpage>2160</lpage><pub-id pub-id-type="pmid">17582161</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burtey</surname><given-names>S.</given-names></name><name><surname>Lossi</surname><given-names>A. M.</given-names></name><name><surname>Bayle</surname><given-names>J.</given-names></name><name><surname>Berland</surname><given-names>Y.</given-names></name><name><surname>Font&#x000e9;s</surname><given-names>M.</given-names></name></person-group> (<year>2002</year>) <source>J. Med. Genet.</source><volume>39</volume>, <fpage>422</fpage>&#x02013;<lpage>429</lpage><pub-id pub-id-type="pmid">12070253</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phakdeekitcharoen</surname><given-names>B.</given-names></name><name><surname>Watnick</surname><given-names>T. J.</given-names></name><name><surname>Ahn</surname><given-names>C.</given-names></name><name><surname>Whang</surname><given-names>D. Y.</given-names></name><name><surname>Burkhart</surname><given-names>B.</given-names></name><name><surname>Germino</surname><given-names>G. G.</given-names></name></person-group> (<year>2000</year>) <source>Kidney Int.</source><volume>58</volume>, <fpage>1400</fpage>&#x02013;<lpage>1412</lpage><pub-id pub-id-type="pmid">11012875</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossetti</surname><given-names>S.</given-names></name><name><surname>Strmecki</surname><given-names>L.</given-names></name><name><surname>Gamble</surname><given-names>V.</given-names></name><name><surname>Burton</surname><given-names>S.</given-names></name><name><surname>Sneddon</surname><given-names>V.</given-names></name><name><surname>Peral</surname><given-names>B.</given-names></name><name><surname>Roy</surname><given-names>S.</given-names></name><name><surname>Bakkaloglu</surname><given-names>A.</given-names></name><name><surname>Komel</surname><given-names>R.</given-names></name><name><surname>Winearls</surname><given-names>C. G.</given-names></name><name><surname>Harris</surname><given-names>P. C.</given-names></name></person-group> (<year>2001</year>) <source>Am. J. Hum. Genet.</source><volume>68</volume>, <fpage>46</fpage>&#x02013;<lpage>63</lpage><pub-id pub-id-type="pmid">11115377</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossetti</surname><given-names>S.</given-names></name><name><surname>Chauveau</surname><given-names>D.</given-names></name><name><surname>Kubly</surname><given-names>V.</given-names></name><name><surname>Slezak</surname><given-names>J. M.</given-names></name><name><surname>Saggar-Malik</surname><given-names>A. K.</given-names></name><name><surname>Pei</surname><given-names>Y.</given-names></name><name><surname>Ong</surname><given-names>A. C.</given-names></name><name><surname>Stewart</surname><given-names>F.</given-names></name><name><surname>Watson</surname><given-names>M. L.</given-names></name><name><surname>Bergstralh</surname><given-names>E. J.</given-names></name><name><surname>Winearls</surname><given-names>C. G.</given-names></name><name><surname>Torres</surname><given-names>V. E.</given-names></name><name><surname>Harris</surname><given-names>P. C.</given-names></name></person-group> (<year>2003</year>) <source>Lancet</source><volume>361</volume>, <fpage>2196</fpage>&#x02013;<lpage>2201</lpage><pub-id pub-id-type="pmid">12842373</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Linke</surname><given-names>W. A.</given-names></name><name><surname>Oberhauser</surname><given-names>A. F.</given-names></name><name><surname>Carrion-Vazquez</surname><given-names>M.</given-names></name><name><surname>Kerkvliet</surname><given-names>J. G.</given-names></name><name><surname>Lu</surname><given-names>H.</given-names></name><name><surname>Marszalek</surname><given-names>P. E.</given-names></name><name><surname>Fernandez</surname><given-names>J. M.</given-names></name></person-group> (<year>2002</year>) <source>Nature</source><volume>418</volume>, <fpage>998</fpage>&#x02013;<lpage>1002</lpage><pub-id pub-id-type="pmid">12198551</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brucale</surname><given-names>M.</given-names></name><name><surname>Sandal</surname><given-names>M.</given-names></name><name><surname>Di Maio</surname><given-names>S.</given-names></name><name><surname>Rampioni</surname><given-names>A.</given-names></name><name><surname>Tessari</surname><given-names>I.</given-names></name><name><surname>Tosatto</surname><given-names>L.</given-names></name><name><surname>Bisaglia</surname><given-names>M.</given-names></name><name><surname>Bubacco</surname><given-names>L.</given-names></name><name><surname>Samor&#x000ec;</surname><given-names>B.</given-names></name></person-group> (<year>2009</year>) <source>Chembiochem.</source><volume>10</volume>, <fpage>176</fpage>&#x02013;<lpage>183</lpage><pub-id pub-id-type="pmid">19067456</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>H. H.</given-names></name><name><surname>Badilla</surname><given-names>C. L.</given-names></name><name><surname>Fernandez</surname><given-names>J. M.</given-names></name></person-group> (<year>2005</year>) <source>J. Mol. Biol.</source><volume>345</volume>, <fpage>817</fpage>&#x02013;<lpage>826</lpage><pub-id pub-id-type="pmid">15588828</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossetti</surname><given-names>S.</given-names></name><name><surname>Chauveau</surname><given-names>D.</given-names></name><name><surname>Walker</surname><given-names>D.</given-names></name><name><surname>Saggar-Malik</surname><given-names>A.</given-names></name><name><surname>Winearls</surname><given-names>C. G.</given-names></name><name><surname>Torres</surname><given-names>V. E.</given-names></name><name><surname>Harris</surname><given-names>P. C.</given-names></name></person-group> (<year>2002</year>) <source>Kidney Int.</source><volume>61</volume>, <fpage>1588</fpage>&#x02013;<lpage>1599</lpage><pub-id pub-id-type="pmid">11967008</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramachandran</surname><given-names>G. N.</given-names></name><name><surname>Ramakrishnan</surname><given-names>C.</given-names></name><name><surname>Sasisekharan</surname><given-names>V.</given-names></name></person-group> (<year>1963</year>) <source>J. Mol. Biol.</source><volume>7</volume>, <fpage>95</fpage>&#x02013;<lpage>99</lpage><pub-id pub-id-type="pmid">13990617</pub-id></mixed-citation></ref></ref-list></back></article>